Please login to the form below

Not currently logged in
Email:
Password:

Teva's Mark Salyer joins Amarin

Takes up newly-created chief commercial officer role

Amarin has appointed Mark Salyer to the newly-created position of chief commercial officer.

He joins the Irish biopharma company from Teva, where he served as general manager of its US respiratory division, and prior to that he held senior roles at GlaxSmithKline and Altana.

Amarin’s president and CEO John Thero said: "Mark brings a strong track record of success coupled with valuable experience and proven leadership to our management team to help drive our anticipated expansion.

"We expect Mark's driven, people-oriented, hands-on approach to work well with our existing commercial organisation to help build on our growth.”

Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of results from the REDUCE-IT cardiovascular outcomes trial. The 8,000-patient study involves its first FDA-approved product, the omega-3 fatty acid-based Vascepa.

21st September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WE Communications

WE’s global and European healthcare hub is based in London, and works with experienced teams across the globe; teams encompassing...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics